The recently concluded AUA annual meeting in Orlando may not go down as one of the most memorable annual meetings in recent years. Nevertheless, it was noteworthy for some interesting news and lively debate on hot-button topics: the safety of certain urologic products, namely, testosterone and transvaginal mesh; new tests for prostate cancer; infection prevention and treatment; and use of an advanced prostate cancer agent in the pre-chemotherapy setting.
History taking in a child who presents with a first episode of nephrolithiasis should include determination of whether there are affected family members, because pediatric patients with a positive family history appear to be at risk for recurrent stones, according to research reported at the AUA annual meeting in Orlando, FL.
A study of contemporary trends in the management of upper tract calculi shows the approach to treatment is influenced by several provider-specific attributes and identifies a steady shift toward increasing use of ureteroscopy.
In this edition of "Coding Q&A," Ray Painter, MD, and Mark Painter also discuss the use of the –59 modifier when instilling mitomycin after TURBT, and whether you can charge for a establishing a treatment on the same day for a patient on whom you have just performed a cystoscopy.
This article examines the relationship between the metabolic syndrome and kidney stone disease. We explain elements of the metabolic workup and practical strategies for prevention and management of stones in patients with the metabolic syndrome.